[1] |
Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management[J]. Cancer Lett, 2016, 379(2):198-205.
|
[2] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
[3] |
Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol, 2014, 60(6):1268-1289.
|
[4] |
Patel T. Cholangiocarcinoma--controversies and challenges[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(4):189-200.
|
[5] |
Zhou H, Wang H, Zhou D, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis[J]. Eur J Cancer, 2010, 46(6):1056-1061.
|
[6] |
Peng NF, Li LQ, Qin X, et al. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus[J]. Ann Surg Oncol, 2011, 18(5):1258-1266.
|
[7] |
Jeong S, Tong Y, Sha M, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Oncotarget, 2017, 8(10):17292-17300.
|
[8] |
Li R, Cai P, Ma KS, et al. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma[J]. Sci Rep, 2016(6):26772.
|
[9] |
Fujita N, Asayama Y, Nishie A, et al. Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT-correlation with clinicopathological findings[J]. Eur Radiol, 2017, 27(2):498-506.
|
[10] |
Koh J, Chung YE, Nahm JH, et al. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI[J]. Eur Radiol, 2016, 26(2):407-416.
|
[11] |
Huang B, Wu L, Lu XY, et al. Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging[J]. Radiology, 2016, 281(1): 150-157.
|
[12] |
Hwang J, Kim YK, Min JH, et al. Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI[J]. Eur Radiol, 2017, DOI: 10.1007/s00330-017-4846-4[Epub ahead of print].
|
[13] |
Kang Y, Lee JM, Kim SH, et al. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images[J]. Radiology, 2012, 264(3):751-760.
|
[14] |
Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings[J]. Radiology, 2011, 260(1):148-157.
|
[15] |
Iavarone M, Piscaglia F, Vavassori S, et al. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis[J]. J Hepatol, 2013, 58(6):1188-1193.
|
[16] |
Rimola J, Forner A, Tremosini S, et al. Non-invasive diagnosis of hepatocellular carcinoma ≤2 cm in cirrhosis. diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI[J]. J Hepatol, 2012, 56(6):1317-1323.
|
[17] |
Zhang N, Gu J, Yin L, et al. Incorporation of alpha-fetoprotein (AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database[J]. Oncotarget, 2016, 7(49):81389-81401.
|
[18] |
Yoh T, Seo S, Hatano E, et al. A novel biomarker-based preoperative prognostic grading system for predicting survival after surgery for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2017, 24(5): 1351-1357.
|
[19] |
Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast was hout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma[J]. Hepatology, 2009, 50(3):791-798.
|
[20] |
Sheng RF, Zeng MS, Rao SX, et al. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study[J]. Clin Imaging, 2014, 38(3):265-272.
|